Canada Markets closed

MYGN Nov 2022 30.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.60000.0000 (0.00%)
As of 03:20PM EDT. Market open.
Full screen
Previous Close1.6000
OpenN/A
Bid1.5000
Ask2.5500
Strike30.00
Expire Date2022-11-18
Day's Range1.6000 - 1.6000
Contract RangeN/A
VolumeN/A
Open Interest43
  • Zacks

    Myriad Genetics (MYGN) Q2 Earnings Top, Gross Margin Down

    Myriad Genetics (MYGN) posts better-than-expected results in Q2 with contributions from most product lines.

  • Zacks

    Myriad Genetics (MYGN) Q2 Earnings and Revenues Top Estimates

    Myriad (MYGN) delivered earnings and revenue surprises of 100% and 6.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Myriad Genetics Reports Second Quarter Financial Results

    Highlights: Revenue of $179.3 million for the quarter ended June 30, 2022 Excluding revenue from divested businesses, revenue increased 7% year-over-year and 9% sequentially from the first quarter of 2022 Diluted GAAP earnings per share (EPS) of $(0.18) and adjusted EPS of $0.04 in the second quarter of 2022Fiscal year 2022 financial guidance updated to reflect additional $20 million investment in research and development, technology, and sales and marketing programsEnded the quarter with $283.6